spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Treatment-Resistant Depression 

 HSMN NewsFeed - 1 May 2024
MagVenture Announces Collaboration with Magnus Medical to Bring the SAINT(R) Neuromodulation System to Market
Devices Neurology
 HSMN NewsFeed - 23 Oct 2018
COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 1 Jun 2018
Amorsa Therapeutics Appoints Jeffrey Wiesen to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 9 Oct 2015
Sorin And Cyberonics Announce Appointment Of Remaining Post-Merger Directors Of Combined Company
Devices Cardiology Neurology Personnel Acquisitions
 HSMN NewsFeed - 20 Aug 2015
Cyberonics and Sorin Provide Merger Update
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 12 May 2015
Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger
Devices Neurology Mergers & Acquisitions Personnel
 HSMN NewsFeed - 8 Dec 2014
Cyberonics Reports Consistently Positive Results From The E-36 And E-37 Studies For VNS Therapy Delivered By AspireSR(R) Generator
Devices Neurology
 HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 20 Feb 2014
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
Devices Regulatory
 HSMN NewsFeed - 12 Sep 2013
Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
Devices Neurology Personnel
 HSMN NewsFeed - 9 Jan 2013
Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
Devices Neurology Personnel
 HSMN NewsFeed - 5 Mar 2012
Alkermes Appoints Mark Stejbach as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2012
Cyberonics Announces FDA Approval of Re-Designed AspireHC(TM) Generator for VNS Therapy
Devices FDA
 HSMN NewsFeed - 31 Oct 2011
Cyberonics Receives FDA Approval for Expansion of MRI Use With VNS Therapy(R) Systems
Devices FDA
 HSMN NewsFeed - 24 Oct 2011
Cyberonics Announces Submission of AspireHC(TM) Generator for Regulatory Approvals
Devices Regulatory
 HSMN NewsFeed - 10 Oct 2011
Cyberonics Announces Resignation of James A. Reinstein, Senior Vice President & Chief Commercial Officer
Devices Personnel
 HSMN NewsFeed - 11 Jul 2011
St. Jude Medical Receives FDA Approval for Expansion of BROADEN Deep Brain Stimulation Study for Depression
Devices Neurology
 HSMN NewsFeed - 1 Feb 2011
Cyberonics Announces FDA Approval of Aspire High Capacity Generator for VNS Therapy
Devices FDA
 HSMN NewsFeed - 5 Nov 2010
Cyberonics Confirms Safety and Efficacy of VNS Therapy(R)
Devices Neurology
 HSMN NewsFeed - 9 Aug 2010
Cyberonics Board of Directors Nominates Jon T. Tremmel
Devices Neurology Personnel
 HSMN NewsFeed - 19 Jan 2010
Cyberonics' VNS Therapy(TM) System Receives Regulatory Approval in Japan
Devices Neurology Regulatory
 HSMN NewsFeed - 24 Nov 2009
SpineGuard elects founder of Danek Medical, Alan Olsen, as a director
Devices Radiology Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 2 Oct 2009
Cyberonics Announces Epilepsy Technology Collaborations
Devices Neurology
 HSMN NewsFeed - 24 Jul 2009
Cyberonics Provides Update on Depression Post-Approval Study
Devices Neurology FDA
 HSMN NewsFeed - 18 May 2009
Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality
Devices Neurology Personnel
 HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Feb 2009
Medtronic Receives FDA HDE Approval to Commercialize the First Deep Brain Stimulation (DBS) Therapy for a Psychiatric Indication in the United States
Devices Neurology
 HSMN NewsFeed - 7 Jan 2009
Cyberonics Provides Business Update on Depression Clinical Trial
Devices Neurology FDA
 HSMN NewsFeed - 31 Oct 2008
Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS
Devices Neurology Reimbursement
 HSMN NewsFeed - 1 Oct 2008
Cyberonics Provides Update on Depression Indication
Devices Neurology
 HSMN NewsFeed - 18 Dec 2007
Cyberonics Licenses Obesity-Related Patents
Devices Licensing
 HSMN NewsFeed - 11 Sep 2007
Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 22 Aug 2007
Cyberonics Announces Organizational Changes
Devices Neurology
 HSMN NewsFeed - 20 Aug 2007
New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
Devices Neurology
 HSMN NewsFeed - 6 Aug 2007
Cyberonics Names James A. Reinstein as Vice President, Sales & Marketing, and General Manager, International and Announces Other Management Changes
Devices Personnel
 HSMN NewsFeed - 14 May 2007
Validus Pharmaceuticals, Inc. Announces Acquisition of Marplan(R) (isocarboxazid) - a Highly Effective Therapy for Treatment-Resistant Depression
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 May 2007
CMS Issues Decision for VNS Therapy in Treatment-Resistant Depression
Devices Neurology Reimbursement
 HSMN NewsFeed - 1 May 2007
Cyberonics Announces Organizational Restructuring
Devices Neurology
 HSMN NewsFeed - 5 Feb 2007
Centers for Medicare and Medicaid Services (CMS) Declines Cyberonics' Formal Request to Expand Coverage of VNS Therapy
Devices Reimbursement
 HSMN NewsFeed - 10 Oct 2006
Northstar Neuroscience Reports Clinical Trial Milestones for the Third Quarter 2006
Devices Neurology
 HSMN NewsFeed - 11 Sep 2006
Cyberonics Provides TRD Post Approval Patient Access and Outcomes Update
Devices Neurology
 HSMN NewsFeed - 12 Jul 2006
Cyberonics Receives FDA Approval for Harmonized/Modularized VNS Therapy System Labeling Format
Devices FDA Neurology
 HSMN NewsFeed - 25 May 2006
Neuroimaging Research Presented at Annual American Psychiatric Association Meeting Provides New Mechanism of Action Insight for VNS Therapy in Treatment- Resistant Depression
Devices Neurology
 HSMN NewsFeed - 23 May 2006
New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2006
Cyberonics Provides Update on Annual American Psychiatric Association Meeting Activities and Recent VNS Therapy Publications
Devices Neurology
 HSMN NewsFeed - 17 May 2006
Cyberonics Announces Patient Enrollment in New TRD Dosing Study
Devices Neurology
Return to NewsFeed  

 Additional items found! 30

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 30 additional stories matching:
Treatment-Resistant Depression
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.